Breaks Categories: News

ThursdayApr 25, 2024 1:00 pm

HempNewsBreaks – Golden Triangle Ventures Inc. (GTVH), Subsidiary Establish Four-Pillar Business Model to Ensure Successful Development of Destino Ranch

Golden Triangle Ventures (OTC: GTVH), a multifaceted consulting company, and its wholly owned subsidiary, Lavish Entertainment (or “Lavish”), have developed a comprehensive four-pillar business model. According to the announcement, the company intends for this key business component to be a critical component moving forward as Lavish Entertainment focuses on creating an industry-leading entertainment business. Specifically, the business model will be used as the company’s flagship project, Destino Ranch, is being developed. The new business model includes four essential key foundational elements: logistics, staffing, equipment and production. The company noted that these specific pillars were carefully identified and organized to complement…

Continue Reading

TuesdayApr 16, 2024 3:42 pm

HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives Approval to Commence Human Pilot Study Evaluating GLP-1, DehydraTECH

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has received approval to begin a new human pilot study. The approval, which was granted by an independent third-party ethics review board, enables Lexaria to move forward with its plan to conduct a GLP-1 study investigating GLP-1 drugs and DehydraTECH(TM). According to the announcement, subject recruitment will begin immediately with the first dosing expected within the next month; the company plans to complete the study this summer. The study will be comprised of two study arms and will include up to nine healthy volunteers. The study is designed to…

Continue Reading

TuesdayApr 16, 2024 1:31 pm

HempNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports on Promising Results from Study on INM-089 Treatment of Dry AMD

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids and proprietary cannabinoid analogs, is reporting on additional preclinical data for INM-089, a proprietary small molecule compound acting as a preferential signaling ligand of cannabinoid receptor 1 (“CB1”) and cannabinoid receptor 2 (“CB2”). The reported data continues to demonstrate positive pharmacological effects in the treatment of dry age-related macular degeneration (“AMD”). According to the announcement, in vivo preclinical studies in AMD disease models show that INM-089 delivers improved retinal pigment epithelium integrity, neuroprotection and photoreceptor improvement. Earlier results showed that INM-089 also preserved retinal function…

Continue Reading

ThursdayApr 11, 2024 3:35 pm

HempNewsBreaks – Boston Hemp Inc Recognized as Nation’s Largest Supplier of Premium, Indoor THCa Flower and Extracts

Boston Hemp, a leading player in the hemp industry, today announced its achievement of being recognized as the nation’s largest supplier of exotic indoor THCa flower and extracts. With a commitment to quality and innovation, Boston Hemp has rapidly emerged as a key player in the thriving market. The company’s dedication to excellence is reflected in its cutting-edge facilities and extraction processes, and Boston Hemp prides itself on delivering premium products to meet the growing demand from consumers seeking high-quality and natural alternatives in all 50 states. “We are thrilled to be recognized as the nation’s largest supplier of premium,…

Continue Reading

ThursdayApr 11, 2024 11:21 am

HempNewsBreaks – Golden Triangle Ventures Inc. (GTVH), Lavish Entertainment Announce Acquisition, Strengthen Position as ‘Powerhouse’ in Entertainment Space

Golden Triangle Ventures (OTC: GTVH), a multifaceted consulting company, and its wholly owned subsidiary, Lavish Entertainment, have closed on the full acquisition of ABI Create, a premier event-management and production company. ABI Create was founded in 2015 by Lavish Entertainment president and COO Marco Antonio Moreno. Since its inception, ABI Create has established a reputation for delivering high-quality productions for a range of large-scale installations at major music festivals, sporting events and conventions. The company has partnered with the NFL Super Bowl, San Diego and New York Comic Con events, EDC and Camp EDC, Bonnaroo Music Festival, the Waste Management…

Continue Reading

TuesdayApr 09, 2024 2:20 pm

HempNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Closes on $3.2M Public Offering

Flora Growth (NASDAQ: FLGC), a cannabis-focused consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000-plus points of distribution around the world, has closed on an underwritten public offering. The offering, which was comprised of 1.7 million common shares, resulted in $3.23 million in gross proceeds for Flora Growth, before deductions. Flora Growth plans to use the funds from the offering for general corporate and working capital needs. Aegis Capital Corp. acted as the sole book-running manager for the offering, which closed on April 8, 2024. In addition, the company announced that its CEO, Clifford…

Continue Reading

MondayApr 08, 2024 1:14 pm

HempNewsBreaks – Astrotech Corp. (NASDAQ: ASTC) Approved as US Government Vendor, Proprietary TRACER 1000 Listed on GSA

Astrotech (NASDAQ: ASTC), an innovative science and technology company, and its wholly owned subsidiary, 1st Detect Corporation, have announced that its TRACER 1000(TM) is now listed in the U.S. General Services Administration (“GSA”) IT Schedule 70, making the company an approved U.S. government vendor. The device can be found under Contract No. GS-35F-250GA with SRI Group LLC, Special Item Number 334290. According to the announcement, IT Schedule 70 is a long-term contract issued to commercial technology vendors that allows sales to the U.S. government, one of the largest buyers of goods and services in the world. A high-performance laboratory instrument of ruggedized mass…

Continue Reading

ThursdayApr 04, 2024 2:23 pm

HempNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Favorable Results from INM-901 Preclinical AD Studies

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, is reporting additional preclinical data demonstrating the positive effects of its INM-901 for the potential treatment of Alzheimer's disease ("AD"). Highlights of the report note that INM-901 receptor binding studies indicate preferential signaling agonism for both cannabinoid 1 (“CB1”) and cannabinoid 2 (“CB2”) and impacts the peroxisome proliferator-activated receptors (“PPAR”) signaling pathway while in vivo studies demonstrate INM-901 reduces neuroinflammation and improves neuronal function. In addition, molecular analysis data explains previously reported observations in behavioral studies on locomotion, memory and cognition. According…

Continue Reading

ThursdayApr 04, 2024 1:19 pm

HempNewsBreaks – Golden Triangle Ventures Inc. (GTVH) to Release Series of CEO Interviews through Collaboration with NowMedia Networks

Golden Triangle Ventures (OTC: GTVH), a multifaceted consulting company, is partnering with NowMedia Networks to release a series of weekly interviews with GTVH CEO and president Steffan Dalsgaard. The series is initially planned for 12 weeks with the objective of sharing the company’s story. This partnership allows GTVH to distribute the interviews to more than 34 million televisions through 10-plus networks; these interviews will be targeting investors, business owners and entrepreneurs. NowMedia TV has built a reputation for offering high-quality bilingual and business-oriented content and will integrate the pioneering perspectives of Golden Triangle Ventures into its acclaimed shows “Power CEOs”…

Continue Reading

TuesdayApr 02, 2024 3:55 pm

HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives New Epilepsy, Anti-Viral Agent Patents

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has received three new patent awards. According to the announcement, the company was awarded two new patents in its epilepsy patent family; both awards were granted in the United States. The U.S. patents, which cover both swallowed capsules and dissolvable oral tablets, complement research indicating DehydraTECH-CBD has potential to decrease epileptic seizures in rodents and to be absorbed into the bloodstream more effectively than the current treatments. In addition, Lexaria was awarded a patent in Japan in is antiviral agent patent family. The new patents bring the total of…

Continue Reading